L’Oréal just announced it acquired a 10% stake in Galderma, characterized as a “pure play dermatology leader” in injectibles with Botox-competitor Dysport, and Restylane filler brands.

Baby boomers and users of weight loss drugs suffering from “facial sagging” are flocking to injectable aesthetic treatments and boosting sales, according to dermatology group Galderma.